Literature DB >> 27648043

Doppler waveform study as indicator of change of portal pressure after administration of octreotide.

Shahbaz Haider1, Qurban Hussain2, Sumera Tabassum3, Bilal Hussain4, Muhammad Rasheed Durrani5, Fayyaz Ahmed6.   

Abstract

OBJECTIVE: To estimate the effect of portal pressure lowering drug 'octreotide', by observing the Doppler waveform before and after the administration of intravenous bolus of octreotide and thus to assess indirectly its efficacy to lower the portal pressure.
METHODS: This quassi experimental study was carried out in Medical Department in collaboration with Radiology Department of Jinnah Postgraduate Medical Center Karachi Pakistan from September 10, 2015 to February 5, 2016. Cases were selected from patients admitted in Medical Wards and those attending Medical OPD. Diagnosis of cirrhosis was confirmed by Clinical Examination and Lab & Imaging investigation in Medical Department. Doppler waveform study was done by experienced radiologist in Radiology Department before and after administration of octreotide. Doppler signals were obtained from the right hepatic vein. Waveform tracings were recorded for five seconds and categorized as 'monophasic', 'biphasic' and 'triphasic'. Waveform changes from one waveform to other were noted and analyzed.
RESULTS: Significant change i.e. from 'monophasic' to 'biphasic' or 'biphasic' to 'triphasic' was seen in 56% cases while 'monophasic' to 'triphasic' was seen in 20% cases. No change was seen in 24% cases. Improvement in waveform reflects lowering of portal vein pressure.
CONCLUSION: Non invasive Hepatic vein Doppler waveform study showed improvement in Doppler waveform after administration of octreotide in 76% cases. Doppler waveform study has the potential of becoming non invasive 'follow up tool' of choice for assessing portal pressure in patients having variceal bleed due to portal hypertension.

Entities:  

Keywords:  Doppler waveform; Hepatic vein; Octreotide; Portal hypertension

Year:  2016        PMID: 27648043      PMCID: PMC5017106          DOI: 10.12669/pjms.324.10275

Source DB:  PubMed          Journal:  Pak J Med Sci        ISSN: 1681-715X            Impact factor:   1.088


  19 in total

1.  Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis.

Authors:  Gennaro D'Amico; Giada Pietrosi; Ilaria Tarantino; Luigi Pagliaro
Journal:  Gastroenterology       Date:  2003-05       Impact factor: 22.682

2.  Doppler sonography and hepatic vein catheterization in portal hypertension: assessment of agreement in evaluating severity and response to treatment.

Authors:  C Merkel; D Sacerdoti; M Bolognesi; G Bombonato; A Gatta
Journal:  J Hepatol       Date:  1998-04       Impact factor: 25.083

3.  Effect of octreotide on systemic, central, and splanchnic haemodynamics in cirrhosis.

Authors:  S Møller; K Brinch; J H Henriksen; U Becker
Journal:  J Hepatol       Date:  1997-05       Impact factor: 25.083

4.  Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension.

Authors:  A Escorsell ; J C Bandi; V Andreu; E Moitinho; J C García-Pagán; J Bosch; J Rodés
Journal:  Gastroenterology       Date:  2001-01       Impact factor: 22.682

5.  A 3-month course of long-acting repeatable octreotide (sandostatin LAR) improves portal hypertension in patients with cirrhosis: a randomized controlled study.

Authors:  Laurent Spahr; Emiliano Giostra; Jean-Louis Frossard; Isabelle Morard; Gilles Mentha; Antoine Hadengue
Journal:  Am J Gastroenterol       Date:  2007-05-03       Impact factor: 10.864

Review 6.  Pharmacological rationale for the use of somatostatin and analogues in portal hypertension.

Authors:  H Reynaert; A Geerts
Journal:  Aliment Pharmacol Ther       Date:  2003-08-15       Impact factor: 8.171

7.  Hemodynamic effects of terlipressin and octreotide administration alone or in combination in portal hypertensive rats.

Authors:  F Oberti; N Veal; M Kaassis; C Pilette; H Rifflet; R Trouvé; P Calès
Journal:  J Hepatol       Date:  1998-07       Impact factor: 25.083

8.  Splenic artery and superior mesenteric artery blood flow: nonsurgical Doppler US measurement in healthy subjects and patients with chronic liver disease.

Authors:  S Sato; K Ohnishi; S Sugita; K Okuda
Journal:  Radiology       Date:  1987-08       Impact factor: 11.105

9.  Estimating effect of terlipressin on portal pressure in cirrhosis by observing hepatic vein Doppler waveform.

Authors:  Qurban Hussain; Shahbaz Haider; Noor Muhammad Solangi; Liaquat Ali; Hammad Liaquat; Fayyaz Ahmed; Sumera Shahbaz
Journal:  J Pak Med Assoc       Date:  2013-05       Impact factor: 0.781

10.  Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective nonrandomized study.

Authors:  Moon Young Kim; Soon Koo Baik; Dong Hun Park; Dae Wook Lim; Jae Woo Kim; Hyun Soo Kim; Sang Ok Kwon; Young Ju Kim; Sei Jin Chang; Samuel S Lee
Journal:  Liver Int       Date:  2007-10       Impact factor: 5.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.